ACRV

STRONG

Acrivon Therapeutics, Inc.

CIK: 0001781174

Buy (50% confidence)

Last activity: Jan 14, 2026

Financial Metrics

As of Sep 30, 2025 (10-Q)

Total Cash $36.02M

Current Ratio 9.80

CEO Buy STRONG

CEO buying activity

Jan 14, 2026

CFO Buy STRONG

CFO buying activity

Jan 14, 2026

Insider	Buys	Net Value	Holdings
Blume-Jensen Peter President and CEO	1	$82K	2,095,771 shares $3.51M
Devroe Eric Chief Operating Officer	1	$17K	75,308 shares $130K
Levy Adam D. Chief Financial Officer	1	$15K	20,983 shares $36K

BUY Blume-Jensen Peter (President and CEO)

49,000 shares @ $1.68

$82K

Jan 14, 2026

Conviction: | View SEC Filing →

BUY Levy Adam D. (Chief Financial Officer)

8,832 shares @ $1.70

$15K

Jan 14, 2026

Conviction: | View SEC Filing →

BUY Devroe Eric (Chief Operating Officer)

10,000 shares @ $1.72

$17K

Jan 13, 2026

Conviction: | View SEC Filing →

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.